review article | Q7318358 |
scholarly article | Q13442814 |
P356 | DOI | 10.1016/S0168-8227(11)70023-7 |
P698 | PubMed publication ID | 21864739 |
P2093 | author name string | Ilias N Migdalis | |
P2860 | cites work | Long-acting insulin analogues versus NPH insulin (human isophane insulin) for type 2 diabetes mellitus | Q24245192 |
Systematic review and meta-analysis of short-acting insulin analogues in patients with diabetes mellitus | Q33218080 | ||
Insulins today and beyond | Q34365284 | ||
A randomised, 52-week, treat-to-target trial comparing insulin detemir with insulin glargine when administered as add-on to glucose-lowering drugs in insulin-naive people with type 2 diabetes | Q36449523 | ||
Intermediate and long-acting insulins: a review of NPH insulin, insulin glargine and insulin detemir | Q36682344 | ||
When basal insulin therapy in type 2 diabetes mellitus is not enough--what next? | Q36742128 | ||
Safety and effectiveness of biphasic insulin aspart 30/70 (NovoMix 30) when switching from human premix insulin in patients with type 2 diabetes: subgroup analysis from the 6-month IMPROVE observational study. | Q37250601 | ||
Insulin-based versus triple oral therapy for newly diagnosed type 2 diabetes: which is better? | Q37364945 | ||
Comparison of once-daily insulin detemir with NPH insulin added to a regimen of oral antidiabetic drugs in poorly controlled type 2 diabetes | Q42605636 | ||
The treat-to-target trial: randomized addition of glargine or human NPH insulin to oral therapy of type 2 diabetic patients | Q44631767 | ||
Reduced hypoglycemia risk with insulin glargine: a meta-analysis comparing insulin glargine with human NPH insulin in type 2 diabetes | Q46406475 | ||
A 26-Week, Randomized, Parallel, Treat-to-Target Trial Comparing Insulin Detemir With NPH Insulin as Add-On Therapy to Oral Glucose-Lowering Drugs in Insulin-Naive People With Type 2 Diabetes | Q59311920 | ||
Long-acting insulin analogues versus NPH human insulin in type 2 diabetes: a meta-analysis | Q81317578 | ||
Long-acting insulin analogs versus human insulins | Q81805752 | ||
P921 | main subject | type 2 diabetes | Q3025883 |
preproinsulin | Q7240673 | ||
P304 | page(s) | S102-4 | |
P577 | publication date | 2011-08-01 | |
P1433 | published in | Diabetes Research and Clinical Practice | Q15750054 |
P1476 | title | Insulin analogs versus human insulin in type 2 diabetes | |
P478 | volume | 93 Suppl 1 |
Q47191041 | Clinical characteristics of type 2 diabetes patients with discordance between HbA1c and fasting plasma glucose in the real world: an analysis of the ORBIT study |
Q39077176 | Comparison of medication adherence in diabetes mellitus patients on human versus analogue insulins |
Q39054758 | Comparison of the impact of human vs analogue insulins on glycosylated haemoglobin in a population with diabetes mellitus |
Q33603478 | Liraglutide administration in type 2 diabetic patients who either received no previous treatment or were treated with an oral hypoglycemic agent showed greater efficacy than that in patients switching from insulin |
Q36515474 | Long-acting basal insulin analogs: latest developments and clinical usefulness |
Q38055517 | Novel non-invasive methods of insulin delivery |